These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 37809646)

  • 41. A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants.
    Wu D; Ye Y; Tang L; Wang AB; Zhang R; Qian ZH; Wang FZ; Zheng H; Huang C; Lv XY; Wang HF; Zhang YY; Pan JJ; Li YF; Lu MX; Wang CS; Ma YT; An ZJ; Rodewald LE; Yin ZD; Wang XY; Wu ZY; Shao YM
    Emerg Microbes Infect; 2022 Dec; 11(1):1950-1958. PubMed ID: 35850623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors Associated With Marshallese and Hispanic Adults' Willingness to Receive a COVID-19 Booster Dose.
    Purvis RS; Vincenzo JL; Spear M; Moore R; Patton SK; Callaghan-Koru J; McElfish PA; Curran GM
    J Prim Care Community Health; 2023; 14():21501319231171440. PubMed ID: 37191303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study.
    Huang M; He R; Chen Q; Song J; Huang H; Zheng S
    Hum Vaccin Immunother; 2023 Dec; 19(1):2166323. PubMed ID: 36951564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COVID-19 Vaccine Initiation and Dose Completion During the SARS-CoV-2 Delta Variant Surge in the United States, December 2020-October 2021.
    Murthy N; Saelee R; Patel Murthy B; Meng L; Shaw L; Gibbs-Scharf L; Harris L; Chorba T; Zell E
    Public Health Rep; 2023; 138(1):183-189. PubMed ID: 36129241
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 Bivalent Booster Vaccination Coverage and Intent to Receive Booster Vaccination Among Adolescents and Adults - United States, November-December 2022.
    Lu PJ; Zhou T; Santibanez TA; Jain A; Black CL; Srivastav A; Hung MC; Kriss JL; Schorpp S; Yankey D; Sterrett N; Fast HE; Razzaghi H; Elam-Evans LD; Singleton JA
    MMWR Morb Mortal Wkly Rep; 2023 Feb; 72(7):190-198. PubMed ID: 36795677
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-19 vaccine equity: a retrospective population-based cohort study examining primary series and first booster coverage among persons with a history of immigration and other residents of Ontario, Canada.
    Wanigaratne S; Lu H; Gandhi S; Shetty J; Stukel TA; Piché-Renaud PP; Brandenberger J; Abdi S; Guttmann A
    Front Public Health; 2023; 11():1232507. PubMed ID: 37744516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relative effectiveness of booster vs. 2-dose mRNA Covid-19 vaccination in the Veterans Health Administration: Self-controlled risk interval analysis.
    Korves C; Izurieta HS; Smith J; Zwain GM; Powell EI; Balajee A; Ryder KM; Young-Xu Y
    Vaccine; 2022 Aug; 40(33):4742-4747. PubMed ID: 35773122
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of Antibody Response and Adverse Effects following Heterologous COVID-19 Vaccine Booster with mRNA Vaccine among Healthcare Workers in Indonesia.
    Soegiarto G; Mahdi BA; Wulandari L; Fahmita KD; Hadmoko ST; Gautama HI; Prasetyaningtyas D; Prasetyo ME; Negoro PP; Arafah N; Purnomosari D; Tinduh D; Husada D; Baskoro A; Fetarayani D; Nurani WK; Oceandy D
    Vaccines (Basel); 2023 Jun; 11(7):. PubMed ID: 37514976
    [No Abstract]   [Full Text] [Related]  

  • 49. COVID-19 Booster Dose Vaccination Coverage and Factors Associated with Booster Vaccination among Adults, United States, March 2022.
    Lu PJ; Srivastav A; Vashist K; Black CL; Kriss JL; Hung MC; Meng L; Zhou T; Yankey D; Masters NB; Fast HE; Razzaghi H; Singleton JA
    Emerg Infect Dis; 2023 Jan; 29(1):133-140. PubMed ID: 36480674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Willingness to pay for booster dose of COVID-19 vaccine among healthcare workers in Taizhou,China.
    Pan SJ; Yang YP; Zhang MX; Tung TH
    Hum Vaccin Immunother; 2022 Nov; 18(5):2063629. PubMed ID: 35522922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 vaccine coverage effectiveness among elderly with geographical information system mapping: what about Indonesia?
    Wulan WR; Widianawati E; Wahyuni AT
    Ther Adv Vaccines Immunother; 2024; 12():25151355241285379. PubMed ID: 39372968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effectiveness of mRNA Vaccine Booster against SARS-CoV-2 Infection and COVID-19 in the Adult Population during the First Three Months of the Omicron Wave in Sicily.
    Vella G; Genovese D; Belluzzo M; Mazzeo L; Pisciotta V; Amodio E
    Healthcare (Basel); 2023 Jan; 11(3):. PubMed ID: 36766880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Who is getting boosted? Disparities in COVID-19 vaccine booster uptake among health care workers.
    Farah W; Breeher LE; Hainy CM; Tommaso CP; Swift MD
    Vaccine X; 2023 Apr; 13():100269. PubMed ID: 36819216
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Booster vaccinations and Omicron: the effects on SARS-CoV-2 antibodies in Dutch blood donors.
    Quee FA; Hogema BM; Slot E; Kruijer S; Molier M; van den Hurk K; Zaaijer HL
    BMC Infect Dis; 2023 Jul; 23(1):464. PubMed ID: 37438703
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study.
    Arbel R; Peretz A; Sergienko R; Friger M; Beckenstein T; Duskin-Bitan H; Yaron S; Hammerman A; Bilenko N; Netzer D
    Lancet Infect Dis; 2023 Aug; 23(8):914-921. PubMed ID: 37062302
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 Incidence and Vaccine Effectiveness in University Staff, 1 March 2020-2 April 2022.
    Cegolon L; Negro C; Pesce M; Filon FL
    Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851360
    [No Abstract]   [Full Text] [Related]  

  • 57. Real-world effectiveness and factors associated with effectiveness of inactivated SARS-CoV-2 vaccines: a systematic review and meta-regression analysis.
    Xu S; Li J; Wang H; Wang F; Yin Z; Wang Z
    BMC Med; 2023 Apr; 21(1):160. PubMed ID: 37106390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. COVID-19 Vaccine Booster Strategies in Light of Emerging Viral Variants: Frequency, Timing, and Target Groups.
    Kelly SL; Le Rutte EA; Richter M; Penny MA; Shattock AJ
    Infect Dis Ther; 2022 Oct; 11(5):2045-2061. PubMed ID: 36094720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spatial and Temporal Analysis of COVID-19 Cases in West Java, Indonesia and Its Influencing Factors.
    Putri DIP; Agustian D; Apriani L; Ilyas R
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833893
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Supporting and inhibiting factors of accepting COVID-19 booster vaccination in the elderly in north Jakarta, Indonesia.
    Cokro F; Sharon ; Hadiyanto
    Pharm Pract (Granada); 2022; 20(4):2748. PubMed ID: 36793907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.